Nina has mentioned in recent interviews about “lumpy spending” as opening the site has a higher cost but after that operation costs drop if I remember correctly.
Australian R&D tax credits ahead as well as the whopping $460m milestone payments for the two regions that have been negotiated. Positive & negative of the milestones are we don’t know the terms as to what will trigger so as to maintain a stronger negotiating position for new markets but data & reaching 144th patient, successful outcome of trials surely should trigger some $$?
Was surprised by the sudden sell off yesterday and I’ll never understand the markets but glad I didn’t buy ETFs with the funds I put into DXB, it’s an exciting time with negotiations ongoing behind the scenes & 70-80% still on the table for regions revenue potential. Market cap adjustments to happen on next data, milestone payments or new partnerships??
What will be the next pivot or trigger people?
- Forums
- ASX - By Stock
- DXB
- Ann: Quarterly Appendix 4C and Activities Report
Ann: Quarterly Appendix 4C and Activities Report, page-71
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.5¢ |
Change
-0.005(1.32%) |
Mkt cap ! $211.7M |
Open | High | Low | Value | Volume |
38.0¢ | 38.0¢ | 37.3¢ | $63.54K | 169.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 108704 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 55003 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 34673 | 0.380 |
3 | 143350 | 0.375 |
10 | 108604 | 0.370 |
14 | 1414634 | 0.365 |
6 | 77485 | 0.360 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 485 | 1 |
0.370 | 10544 | 2 |
0.380 | 39818 | 2 |
0.385 | 43000 | 2 |
0.390 | 257524 | 2 |
Last trade - 10.05am 04/10/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |